Evaluation of rivaroxaban for distal deep vein thrombosis - a single-center, randomized, open-label, assessor-blind, parallel group, exploratory study
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- Acronyms ISE calf DVT study
- 13 Sep 2017 Status changed from not yet recruiting to discontinued.
- 30 Jul 2017 Planned initiation date changed from 10 Jul 2017 to 2 Apr 2018.
- 11 Jul 2017 New trial record